A detailed history of Hotaling Investment Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hotaling Investment Management, LLC holds 6,195 shares of VRTX stock, worth $2.79 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
6,195
Previous 6,169 0.42%
Holding current value
$2.79 Million
Previous $1.79 Million 0.17%
% of portfolio
0.81%
Previous 0.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $7,429 - $8,358
26 Added 0.42%
6,195 $1.79 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $14,512 - $16,193
-53 Reduced 0.85%
6,169 $1.79 Million
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $1.46 Million - $1.82 Million
6,222 New
6,222 $1.75 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hotaling Investment Management, LLC Portfolio

Follow Hotaling Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hotaling Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hotaling Investment Management, LLC with notifications on news.